# Prakash Deedwania

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/prakash-deedwania/

## Facts

| Field | Value |
| --- | --- |
| Citations | 33,702 |
| Field | Heart Failure Treatment and Management |
| h-index | 81 |
| i10-index | 287 |
| Last Known Institution | Mount Auburn Hospital |
| OpenAlex ID | https://openalex.org/A5078294568 |
| ORCID iD | https://orcid.org/0000-0002-5652-9347 |
| Works | 650 |

## Researcher papers

- [Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)](https://scholariq.org/papers/randomised-trial-of-losartan-versus-captopril-in-patients-over-65-with-heart/)
- [Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure](https://scholariq.org/papers/effects-of-controlled-release-metoprolol-on-total-mortality-hospitalizations-and/)
- [Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia](https://scholariq.org/papers/amiodarone-in-patients-with-congestive-heart-failure-and-asymptomatic/)
- [Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials](https://scholariq.org/papers/intensive-glycemic-control-and-the-prevention-of-cardiovascular-events-2/)
- [National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2](https://scholariq.org/papers/national-lipid-association-recommendations-for-patient-centered-management-of/)
- [Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial](https://scholariq.org/papers/cardiovascular-safety-and-efficacy-of-the-pcsk9-inhibitor-evolocumab-in-patients/)
- [Hyperglycemia and Acute Coronary Syndrome](https://scholariq.org/papers/hyperglycemia-and-acute-coronary-syndrome/)
- [Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials](https://scholariq.org/papers/intensive-glycemic-control-and-the-prevention-of-cardiovascular-events/)
- [Predictors of total mortality and sudden death in mild to moderate heart failure](https://scholariq.org/papers/predictors-of-total-mortality-and-sudden-death-in-mild-to-moderate-heart-failure/)
- [Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations](https://scholariq.org/papers/results-of-the-national-cholesterol-education-ncep-program-evaluation-project/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Researcher university

- [Mount Auburn Hospital](https://scholariq.org/institutions/mount-auburn-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.